Christer Nordstedt

Christer Nordstedt

Chief Executive Officer at
Oblique Therapeutics AB
64 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Christer Nordstedt is a Chief Executive Officer at Oblique Therapeutics AB and a Chairman at Snevringe AB. He is on the Board of Directors at CINDA PHARMA AB. Dr. Nordstedt was previously employed as a Chief Executive Officer by Vivesto AB, a Chairman by Wntresearch AB, a Senior Vice President-Research & Development by Orion Oyj, a Senior Vice President by Eli Lilly Sweden AB, a Vice President by AstraZeneca AB, a Senior Vice President by Hoffman-LaRoche F & Co. AG, and a Global Research Manager by Teva GmbH.
He also served on the board at IRLAB Therapeutics AB, Fermion Ltd. and Orion Diagnostica AB. He received his doctorate degree from Karolinska Institutet.

Christer Nordstedt active positions

CompaniesPositionStart
Snevringe AB
Chairman -
Chief Executive Officer 01/12/2022
Director/Board Member -

Former positions of Christer Nordstedt

CompaniesPositionEnd
VIVESTO AB Chief Executive Officer 30/11/2022
ORION OYJ Chief Tech/Sci/R&D Officer 05/03/2020
Fermion Ltd.
Director/Board Member 01/01/2020
Orion Diagnostica AB
Director/Board Member 01/01/2019
Corporate Officer/Principal 01/02/2017
See the detail of Christer Nordstedt's experience

Training of Christer Nordstedt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Distribution Services

Orion Diagnostica AB

Fermion Ltd.

Health Technology

Health Technology

Snevringe AB

Commercial Services

  1. Stock Market
  2. Insiders
  3. Christer Nordstedt